Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma [Phase 2]
A Phase 2 trial evaluating gefitinib plus docetaxel as salvage therapy in advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
A Mayo Clinic–sponsored clinical trial investigated the role of CXCR2 ligands and the CXCR2 signaling axis in pancreatic cancer, including c…
-
CLINICAL_TRIALS research · 2016-01-07Clinical Trial Update: Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer
A clinical trial update describing systematic lymph node sampling and analysis in patients with pancreatic cancer. The current trial status …
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Loop-tipped Guidewire in Selective Biliary Cannulation [NA]
A clinical trial update notes completion of a study evaluating loop-tipped guidewire use for selective biliary cannulation, sponsored by Ajo…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.
A completed clinical trial evaluated circulating tumor cell detection in pancreatic cancer patients undergoing cryosurgery with DC-CIK cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-12-28Clinical Trial Update: Quality of Life After Radiofrequency Ablation of Pancreatic Cancer [NA]
This trial update reports on quality of life outcomes from a completed study of radiofrequency ablation for pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating a combination of gemcitabine, capecitabine, and bevacizumab in patients with metastatic or unresectable pa…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer [NA]
This completed clinical trial evaluated the use of multiple needles during endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for…
-
CLINICAL_TRIALS research · 2015-12-18Clinical Trial Update: Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis [Phase 2]
Clinical trial update reporting a Phase 2 study of combining radiofrequency ablation with S-1 for pancreatic cancer with liver metastasis; c…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery [Phase 2]
Phase 2 study evaluating gemcitabine plus oxaliplatin (GEMOX) in patients with resectable pancreatic cancer. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 3]
Phase 3 trial evaluating gemcitabine with or without capecitabine and/or radiation therapy or gemcitabine with or without erlotinib in local…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Study of Pemetrexed for Second-Line Pancreas Cancer [Phase 2]
A Phase 2 study of pemetrexed for second-line pancreatic cancer was terminated, with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-11-20Clinical Trial Update: Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants
This clinical trial update describes collecting and storing blood samples from patients with pancreatic cancer and healthy participants for …
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer [Phase 3]
SWOG's Phase 3 trial comparing gemcitabine with or without cetuximab as first-line therapy for locally advanced pancreatic cancer has comple…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial (S9924 R115777) evaluating tipifarnib in locally advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas [Phase 1]
A Phase 1 trial evaluating ganitumab with gemcitabine and radiation therapy, followed by ganitumab with capecitabine and maintenance therapy…
-
CLINICAL_TRIALS research · 2015-11-10Clinical Trial Update: Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer [Phase 1]
Phase I trial update of LCL161 in combination with gemcitabine and nab-paclitaxel for metastatic pancreatic cancer. The status is currently …
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer [Phase 1, Phase 2]
This update reports that a phase 1/phase 2 trial of gemcitabine with Abraxane and dose-escalated radiotherapy for locally advanced unresecta…
-
FDA approval · 2015-10-22FDA Approved: ONIVYDE — Original Application (Ipsen Biopharmaceuticals, Inc.)
FDA approved ONIVYDE (irinotecan hydrochloride liposome injection) under the Original Application from Ipsen Biopharmaceuticals, Inc., for p…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update covers a randomized Phase 1/2 study comparing ICE (irinotecan, cetuximab, everolimus) with CapOx (capecitabine, o…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Effects of Dexmedetomidine During IRE Procedures for Solid Tumours [Phase 4]
Phase 4 clinical trial update on the use of Dexmedetomidine during irreversible electroporation procedures for liver and pancreatic cancers;…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso [Phase 1]
Phase 1 study of CART-meso, a mesothelin-targeted CAR-T cell therapy, in patients with relapsed or chemotherapy-refractory advanced cancers,…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer [Phase 1]
Phase 1 trial evaluating a triple-drug combination of capecitabine, docetaxel, and gemcitabine in advanced pancreatic cancer; results have b…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival [Phase 2]
A Phase 2 study of erlotinib (Tarceva) in combination with gemcitabine in unresectable or metastatic pancreatic cancer evaluates whether tre…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Nimotuzumab in Adults With Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update indicating nimotuzumab trials in adults with advanced or metastatic pancreatic cancer have completed Phase 2 and Phase…